Cannabis Clinical Research Closer To Approval

CANNABIS-LEAF

The Food and Drug Administration (FDA) published draft guidance on developing cannabis-based drugs on Tuesday.

This comes weeks after the White House completed its review of the document, clearing its path for public release.

FDA is still in the process of developing regulations that could allow for CBD to be marketed as a food item or dietary supplement, but in the meantime it has worked to create these new research guidelines for drug manufacturing.

FULL STORY HERE

Leave a Reply

Your email address will not be published. Required fields are marked *

Invite & Earn

X
Signup to start sharing your link
Signup